Clinical trial
A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in…
NCT00099177 · Hoffmann-La Roche, Industry · Terminated
Key facts
| NCT number | NCT00099177 |
|---|---|
| Title | A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain |
| Official title | A Randomized, Double-blind Study of the Effect of Bondronat Compared With Zoledronic Acid on Pain in Patients With Malignant Bone Disease Experiencing Moderate to Severe Pain |
| Lead sponsor | Hoffmann-La Roche, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Pain, Bone Neoplasm, Neoplasm Metastasis |
| Intervention type | Drug |
| Interventions | ibandronate [Bondronat], zoledronic acid |
| Enrollment | 96 |
| Start date | Aug 1, 2005 |
| Primary completion | Dec 1, 2007 |
| Completion | Dec 1, 2007 |
| First posted | Dec 10, 2004 |
| Last update posted | Aug 16, 2017 |
| Countries | Argentina, Australia, Chile, Germany, Greece, Guatemala, Hungary, Italy, Mexico, Panama, Poland, Puerto Rico and 4 more |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: